(Q38197344)

30 August 2017

1 reference

title

Methylglyoxal in diabetes: link to treatment, glycaemic control and biomarkers of complications (English)

1 reference

30 August 2017

0 references

Paul J Beisswenger

1

1 reference

30 August 2017

1 April 2014

1 reference

Biochemical Society Transactions

30 August 2017

1 reference

30 August 2017

42

1 reference

30 August 2017

2

1 reference

30 August 2017

450-456

1 reference

Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050.

30 August 2017

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Impaired fasting glucose and impaired glucose tolerance: implications for care

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Economic costs of diabetes in the U.S. in 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Biomarker discovery for kidney diseases by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

The role of the amadori product in the complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Glycation products as markers and predictors of the progression of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Glycoxidation and lipoxidation in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Rising epidemic of diabetes and hypertension in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification--a role in pathogenesis and antiproliferative chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Postprandial hyperglycemia and diabetes complications: is it time to treat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Role of hyperglycemia in nitrotyrosine postprandial generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Glycation products and the pathogenesis of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Metformin: intrinsic vasculoprotective properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Increased glycation and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

Unchanged incidence of microalbuminuria in children with type 1 diabetes since 1986: a UK based inception cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20130275

21 January 2018

Identifiers

DOI

10.1042/BST20130275

1 reference

30 August 2017

1 reference

PubMed ID

24646259